Acción 688639 ANHUI HUAHENG BIOTECHNOLOGY CO., LTD.
Añadir a una lista
Para utilizar esta función debe ser un cliente o miembro.
ConéctateRegístrate

Otros idiomas Anhui Huaheng Biotechnology Co., Ltd.

Acciones

688639

CNE1000052M6

Precio de cierre Shanghai S.E.
Otros sitios de cotización
 00:00:00 30/04/2024 		Varia. Cinco días. Varia. 1 de enero.
118,4 CNY +1,07 % Gráfico intradía de Anhui Huaheng Biotechnology Co., Ltd. +10,14 % -5,94 %
22/04 El beneficio del primer trimestre de Anhui Huaheng Biotechnology aumenta un 7 MT
22/04 El beneficio de Anhui Huaheng Biotechnology en 2023 se dispara un 40 MT

Otros idiomas

Buscar
Ver los resultados
Desbloquee todas las noticias sobre todas las empresas: ¡No vuelvas a perderse una oportunidad de inversión rentable!
Inscripción 100% Gratuita
Anhui Huaheng Biotechnology's Q1 Profit Jumps 7%
Anhui Huaheng Biotechnology's 2023 Profit Jumps 40%
Certain A Shares of Anhui Huaheng Biotechnology Co., Ltd. are subject to a Lock-Up Agreement Ending on 22-APR-2024.
Anhui Huaheng Biotechnology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024
Rate Cut Plans Boost China Stocks; Huaheng Biotechnology Jumps 9%
Huaheng Biotechnology to Set Up Subsidiary, Production Plant for 700 Million Yuan
Huaheng Biotechnology Gets Rights to Ouhe Biotechnology's Biological Arginine Production Technology
Anhui Huaheng Biotechnology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023
Tranche Update on Anhui Huaheng Biotechnology Co., Ltd.'s Equity Buyback Plan announced on August 11, 2023.
Anhui Huaheng Biotechnology Co., Ltd.'s Equity Buyback announced on August 11, 2023, has closed with 496,600 shares, representing 0.32% for CNY 49.98 million.
Anhui Huaheng Biotechnology Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023
Tranche Update on Anhui Huaheng Biotechnology Co., Ltd.'s Equity Buyback Plan announced on August 11, 2023.
Anhui Huaheng Biotechnology Co., Ltd.(XSSC:688639) added to S&P Global BMI Index
Anhui Huaheng Biotechnology Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023
Wuhan Ruijiakang Biotechnology Co., Ltd. announced that it has received CNY 20 million in funding from Anhui Huaheng Biotechnology Co., Ltd., Suzhou Kaifeng Zhengde Investment Management Co., Ltd.
Anhui Huaheng Biotechnology Co., Ltd. announces an Equity Buyback for CNY 50 million worth of its shares.
Anhui Huaheng Biotechnology Co., Ltd. authorizes a Buyback Plan.
Anhui Huaheng Biotechnology Acquires Marketing Rights to Ouhe Biotechnology's Phytic Acid Technology
Anhui Huaheng Biotechnology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023
Anhui Huaheng Biotechnology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022
No hay resultados para esta búsqueda
Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Filtros

Buscar

Fecha de publicación

De

Hasta

  1. Bolsa de valores
  2. Acciones
  3. Acción 688639
  4. Noticias Anhui Huaheng Biotechnology Co., Ltd.
  5. Otros idiomas